Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Gately

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblastsR Chizzonite, T Truitt, F J Podlaski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1995
Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activityP Ling, M K Gately, U Gubler, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunitsD H Presky, H Yang, L J Minetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1994
Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selectionS C Morris, K B Madden, J J Adamovicz, et al.
European Journal of Immunology|August 1, 1993
Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cellsT Germann, M K Gately, D S Schoenhaut, et al.
International Immunology|April 30, 1999
IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenesF Brombacher, A Dorfmüller, J Magram, et al.
European Journal of Immunology|July 1, 1996
Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell responseF Mattner, J Magram, J Ferrante, et al.
The Journal of Experimental Medicine|October 1, 1993
Antitumor and antimetastatic activity of interleukin 12 against murine tumorsM J Brunda, L Luistro, R R Warrier, et al.
International Immunology|October 1, 1995
Administration of IL-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgET Germann, S Guckes, M Bongartz, et al.
Annals of the New York Academy of Sciences|October 31, 1996
IL-12-deficient mice are defective but not devoid of type 1 cytokine responsesJ Magram, J Sfarra, S Connaughton, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblastsR Chizzonite, T Truitt, F J Podlaski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1995
Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activityP Ling, M K Gately, U Gubler, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunitsD H Presky, H Yang, L J Minetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1994
Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selectionS C Morris, K B Madden, J J Adamovicz, et al.
European Journal of Immunology|August 1, 1993
Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cellsT Germann, M K Gately, D S Schoenhaut, et al.
International Immunology|April 30, 1999
IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenesF Brombacher, A Dorfmüller, J Magram, et al.
European Journal of Immunology|July 1, 1996
Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell responseF Mattner, J Magram, J Ferrante, et al.
The Journal of Experimental Medicine|October 1, 1993
Antitumor and antimetastatic activity of interleukin 12 against murine tumorsM J Brunda, L Luistro, R R Warrier, et al.
International Immunology|October 1, 1995
Administration of IL-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgET Germann, S Guckes, M Bongartz, et al.
Annals of the New York Academy of Sciences|October 31, 1996
IL-12-deficient mice are defective but not devoid of type 1 cytokine responsesJ Magram, J Sfarra, S Connaughton, et al.
Pageof 11